Global Progesterone API Supply, Demand and Key Producers, 2026-2032
The global Progesterone API market size is expected to reach $ 238 million by 2032, rising at a market growth of 5.4% CAGR during the forecast period (2026-2032).
Progesterone API refers to the steroid hormone active pharmaceutical ingredient used in the manufacture of progesterone finished dosage forms and represents the most mature and industrialized product within the progestogen API category. It is primarily applied in gynecological endocrine therapy, luteal support in assisted reproductive technology (ART), hormone replacement therapy, and selected peri-menopausal indications. Upstream inputs mainly consist of plant sterol-based starting materials and key steroid intermediates, supported by organic solvents, reagents and catalysts, and purification and separation materials; manufacturing involves multi-step steroid transformations and requires tight control of process stability, impurity profiles, and polymorph consistency. Downstream customers mainly include manufacturers of progesterone finished dosage forms (oral capsules, vaginal delivery formulations, and injectables), CDMOs/CMOs engaged in hormone-related programs, and generic pharmaceutical companies serving domestic and export markets. The global nameplate capacity for Progesterone API in 2025 is estimated at approximately 540 metric tons, with actual sales of around 452.6 metric tons. As a highly commoditized steroid API with transparent pricing, the global average ex-factory price is estimated at approximately USD 350 per kg. Overall industry gross margin typically falls within the range of 35%?43%, reflecting differences in process efficiency, scale, environmental compliance, and regulatory requirements.
The progesterone API market is characterized by a high degree of maturity combined with clear structural differentiation. On the one hand, progesterone is a classic steroid hormone API with well-established synthesis routes and standardized quality requirements, resulting in a relatively stable global supply base where competition is largely driven by scale and cost efficiency. On the other hand, differences in regulatory expectations, documentation depth, and ongoing compliance across regions create distinct supplier tiers within the same product category, allowing highly compliant and conventional supply segments to coexist.
From the demand perspective, downstream consumption of progesterone APIs is closely linked to gynecological endocrine therapies and assisted reproductive applications, giving the market a certain degree of demand rigidity while also making it sensitive to changes in healthcare policies, clinical guidelines, and reimbursement environments. As awareness of women's health continues to increase and assisted reproduction becomes more standardized, finished-dose manufacturers place greater emphasis on long-term supply reliability, batch-to-batch consistency, and traceability when sourcing APIs, shifting procurement decisions from pure price comparisons to more comprehensive supplier assessments.
Looking ahead, industry evolution is expected to focus on supply-side consolidation and rising compliance thresholds. Manufacturers with integrated capabilities spanning raw materials, intermediates, and APIs are better positioned to strengthen cost control and delivery stability, while stricter environmental, safety, and regulatory oversight is likely to accelerate the exit of subscale or non-compliant capacity, driving the industry toward higher levels of standardization and concentration. At the same time, persistent segmentation between regulated and emerging markets will continue, encouraging suppliers to adopt differentiated service offerings and flexible commercial models.
Against this backdrop of both momentum and constraint, the market faces a balanced set of drivers and challenges. Long-term demand is supported by demographic shifts, increasing utilization of assisted reproductive services, and improved access to healthcare in emerging markets. Conversely, the inherent complexity of multi-step steroid synthesis, rising environmental and safety compliance costs, volatility in upstream raw material prices, and ongoing price competition exert pressure on margins and investment decisions. Companies that can balance compliance expertise, scale advantages, and strong customer relationships are more likely to maintain resilience and achieve sustainable development over time.
This report studies the global Progesterone API production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Progesterone API and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Progesterone API that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Progesterone API total production and demand, 2021-2032, (Tons)
Global Progesterone API total production value, 2021-2032, (USD Million)
Global Progesterone API production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Tons), (based on production site)
Global Progesterone API consumption by region & country, CAGR, 2021-2032 & (Tons)
U.S. VS China: Progesterone API domestic production, consumption, key domestic manufacturers and share
Global Progesterone API production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Tons)
Global Progesterone API production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Tons)
Global Progesterone API production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Tons)
This report profiles key players in the global Progesterone API market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer CentreOne, EUROAPI, TAPI, Axplora, Steroid SpA, Symbiotec Pharmalab, Sun Pharmaceutical Industries, Cipla, Zydus Lifesciences, Aurobindo Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Progesterone API market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Tons) and average price (US$/kg) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Progesterone API Market, By Region:
1. How big is the global Progesterone API market?
2. What is the demand of the global Progesterone API market?
3. What is the year over year growth of the global Progesterone API market?
4. What is the production and production value of the global Progesterone API market?
5. Who are the key producers in the global Progesterone API market?
6. What are the growth factors driving the market demand?
Progesterone API refers to the steroid hormone active pharmaceutical ingredient used in the manufacture of progesterone finished dosage forms and represents the most mature and industrialized product within the progestogen API category. It is primarily applied in gynecological endocrine therapy, luteal support in assisted reproductive technology (ART), hormone replacement therapy, and selected peri-menopausal indications. Upstream inputs mainly consist of plant sterol-based starting materials and key steroid intermediates, supported by organic solvents, reagents and catalysts, and purification and separation materials; manufacturing involves multi-step steroid transformations and requires tight control of process stability, impurity profiles, and polymorph consistency. Downstream customers mainly include manufacturers of progesterone finished dosage forms (oral capsules, vaginal delivery formulations, and injectables), CDMOs/CMOs engaged in hormone-related programs, and generic pharmaceutical companies serving domestic and export markets. The global nameplate capacity for Progesterone API in 2025 is estimated at approximately 540 metric tons, with actual sales of around 452.6 metric tons. As a highly commoditized steroid API with transparent pricing, the global average ex-factory price is estimated at approximately USD 350 per kg. Overall industry gross margin typically falls within the range of 35%?43%, reflecting differences in process efficiency, scale, environmental compliance, and regulatory requirements.
The progesterone API market is characterized by a high degree of maturity combined with clear structural differentiation. On the one hand, progesterone is a classic steroid hormone API with well-established synthesis routes and standardized quality requirements, resulting in a relatively stable global supply base where competition is largely driven by scale and cost efficiency. On the other hand, differences in regulatory expectations, documentation depth, and ongoing compliance across regions create distinct supplier tiers within the same product category, allowing highly compliant and conventional supply segments to coexist.
From the demand perspective, downstream consumption of progesterone APIs is closely linked to gynecological endocrine therapies and assisted reproductive applications, giving the market a certain degree of demand rigidity while also making it sensitive to changes in healthcare policies, clinical guidelines, and reimbursement environments. As awareness of women's health continues to increase and assisted reproduction becomes more standardized, finished-dose manufacturers place greater emphasis on long-term supply reliability, batch-to-batch consistency, and traceability when sourcing APIs, shifting procurement decisions from pure price comparisons to more comprehensive supplier assessments.
Looking ahead, industry evolution is expected to focus on supply-side consolidation and rising compliance thresholds. Manufacturers with integrated capabilities spanning raw materials, intermediates, and APIs are better positioned to strengthen cost control and delivery stability, while stricter environmental, safety, and regulatory oversight is likely to accelerate the exit of subscale or non-compliant capacity, driving the industry toward higher levels of standardization and concentration. At the same time, persistent segmentation between regulated and emerging markets will continue, encouraging suppliers to adopt differentiated service offerings and flexible commercial models.
Against this backdrop of both momentum and constraint, the market faces a balanced set of drivers and challenges. Long-term demand is supported by demographic shifts, increasing utilization of assisted reproductive services, and improved access to healthcare in emerging markets. Conversely, the inherent complexity of multi-step steroid synthesis, rising environmental and safety compliance costs, volatility in upstream raw material prices, and ongoing price competition exert pressure on margins and investment decisions. Companies that can balance compliance expertise, scale advantages, and strong customer relationships are more likely to maintain resilience and achieve sustainable development over time.
This report studies the global Progesterone API production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Progesterone API and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Progesterone API that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Progesterone API total production and demand, 2021-2032, (Tons)
Global Progesterone API total production value, 2021-2032, (USD Million)
Global Progesterone API production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Tons), (based on production site)
Global Progesterone API consumption by region & country, CAGR, 2021-2032 & (Tons)
U.S. VS China: Progesterone API domestic production, consumption, key domestic manufacturers and share
Global Progesterone API production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Tons)
Global Progesterone API production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Tons)
Global Progesterone API production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Tons)
This report profiles key players in the global Progesterone API market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer CentreOne, EUROAPI, TAPI, Axplora, Steroid SpA, Symbiotec Pharmalab, Sun Pharmaceutical Industries, Cipla, Zydus Lifesciences, Aurobindo Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Progesterone API market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Tons) and average price (US$/kg) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Progesterone API Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- High-compliance
- Standard Generic-grade
- Oral Formulation
- Injectable
- Vaginal Delivery Formulations
- Luteal Phase Support in Assisted Reproductive Technology
- Treatment of Luteal Phase Deficiency
- Others
- Finished Dosage Form Manufacturers
- CDMO/CMO
- Others
- Pfizer CentreOne
- EUROAPI
- TAPI
- Axplora
- Steroid SpA
- Symbiotec Pharmalab
- Sun Pharmaceutical Industries
- Cipla
- Zydus Lifesciences
- Aurobindo Pharma
- Tianjin Tianyao Pharmaceuticals
- Zhejiang Xianju Pharmaceutical
- Saituo Biological Technology
- Zhejiang Xianju Xianle Pharmaceutical
- Jiangsu Lianhuan Pharmaceutical
- Zhejiang Xianju Junye Pharmaceutical
- Zhejiang Shenzhou Pharmaceutical
1. How big is the global Progesterone API market?
2. What is the demand of the global Progesterone API market?
3. What is the year over year growth of the global Progesterone API market?
4. What is the production and production value of the global Progesterone API market?
5. Who are the key producers in the global Progesterone API market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Progesterone API Introduction
1.2 World Progesterone API Supply & Forecast
1.2.1 World Progesterone API Production Value (2021 & 2025 & 2032)
1.2.2 World Progesterone API Production (2021-2032)
1.2.3 World Progesterone API Pricing Trends (2021-2032)
1.3 World Progesterone API Production by Region (Based on Production Site)
1.3.1 World Progesterone API Production Value by Region (2021-2032)
1.3.2 World Progesterone API Production by Region (2021-2032)
1.3.3 World Progesterone API Average Price by Region (2021-2032)
1.3.4 North America Progesterone API Production (2021-2032)
1.3.5 Europe Progesterone API Production (2021-2032)
1.3.6 China Progesterone API Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Progesterone API Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Progesterone API Major Market Trends
2 DEMAND SUMMARY
2.1 World Progesterone API Demand (2021-2032)
2.2 World Progesterone API Consumption by Region
2.2.1 World Progesterone API Consumption by Region (2021-2026)
2.2.2 World Progesterone API Consumption Forecast by Region (2027-2032)
2.3 United States Progesterone API Consumption (2021-2032)
2.4 China Progesterone API Consumption (2021-2032)
2.5 Europe Progesterone API Consumption (2021-2032)
2.6 Japan Progesterone API Consumption (2021-2032)
2.7 South Korea Progesterone API Consumption (2021-2032)
2.8 ASEAN Progesterone API Consumption (2021-2032)
2.9 India Progesterone API Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Progesterone API Production Value by Manufacturer (2021-2026)
3.2 World Progesterone API Production by Manufacturer (2021-2026)
3.3 World Progesterone API Average Price by Manufacturer (2021-2026)
3.4 Progesterone API Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Progesterone API Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Progesterone API in 2025
3.5.3 Global Concentration Ratios (CR8) for Progesterone API in 2025
3.6 Progesterone API Market: Overall Company Footprint Analysis
3.6.1 Progesterone API Market: Region Footprint
3.6.2 Progesterone API Market: Company Product Type Footprint
3.6.3 Progesterone API Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Progesterone API Production Value Comparison
4.1.1 United States VS China: Progesterone API Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Progesterone API Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Progesterone API Production Comparison
4.2.1 United States VS China: Progesterone API Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Progesterone API Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Progesterone API Consumption Comparison
4.3.1 United States VS China: Progesterone API Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Progesterone API Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Progesterone API Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Progesterone API Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Progesterone API Production Value (2021-2026)
4.4.3 United States Based Manufacturers Progesterone API Production (2021-2026)
4.5 China Based Progesterone API Manufacturers and Market Share
4.5.1 China Based Progesterone API Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Progesterone API Production Value (2021-2026)
4.5.3 China Based Manufacturers Progesterone API Production (2021-2026)
4.6 Rest of World Based Progesterone API Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Progesterone API Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Progesterone API Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Progesterone API Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Progesterone API Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 High-compliance
5.2.2 Standard Generic-grade
5.3 Market Segment by Type
5.3.1 World Progesterone API Production by Type (2021-2032)
5.3.2 World Progesterone API Production Value by Type (2021-2032)
5.3.3 World Progesterone API Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY FORMULATION
6.1 World Progesterone API Market Size Overview by Formulation: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Formulation
6.2.1 Oral Formulation
6.2.2 Injectable
6.2.3 Vaginal Delivery Formulations
6.3 Market Segment by Formulation
6.3.1 World Progesterone API Production by Formulation (2021-2032)
6.3.2 World Progesterone API Production Value by Formulation (2021-2032)
6.3.3 World Progesterone API Average Price by Formulation (2021-2032)
7 MARKET ANALYSIS BY CLINICAL INDICATION
7.1 World Progesterone API Market Size Overview by Clinical Indication: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Clinical Indication
7.2.1 Luteal Phase Support in Assisted Reproductive Technology
7.2.2 Treatment of Luteal Phase Deficiency
7.2.3 Others
7.3 Market Segment by Clinical Indication
7.3.1 World Progesterone API Production by Clinical Indication (2021-2032)
7.3.2 World Progesterone API Production Value by Clinical Indication (2021-2032)
7.3.3 World Progesterone API Average Price by Clinical Indication (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Progesterone API Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Finished Dosage Form Manufacturers
8.2.2 CDMO/CMO
8.2.3 Others
8.3 Market Segment by Application
8.3.1 World Progesterone API Production by Application (2021-2032)
8.3.2 World Progesterone API Production Value by Application (2021-2032)
8.3.3 World Progesterone API Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Pfizer CentreOne
9.1.1 Pfizer CentreOne Details
9.1.2 Pfizer CentreOne Major Business
9.1.3 Pfizer CentreOne Progesterone API Product and Services
9.1.4 Pfizer CentreOne Progesterone API Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Pfizer CentreOne Recent Developments/Updates
9.1.6 Pfizer CentreOne Competitive Strengths & Weaknesses
9.2 EUROAPI
9.2.1 EUROAPI Details
9.2.2 EUROAPI Major Business
9.2.3 EUROAPI Progesterone API Product and Services
9.2.4 EUROAPI Progesterone API Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 EUROAPI Recent Developments/Updates
9.2.6 EUROAPI Competitive Strengths & Weaknesses
9.3 TAPI
9.3.1 TAPI Details
9.3.2 TAPI Major Business
9.3.3 TAPI Progesterone API Product and Services
9.3.4 TAPI Progesterone API Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 TAPI Recent Developments/Updates
9.3.6 TAPI Competitive Strengths & Weaknesses
9.4 Axplora
9.4.1 Axplora Details
9.4.2 Axplora Major Business
9.4.3 Axplora Progesterone API Product and Services
9.4.4 Axplora Progesterone API Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Axplora Recent Developments/Updates
9.4.6 Axplora Competitive Strengths & Weaknesses
9.5 Steroid SpA
9.5.1 Steroid SpA Details
9.5.2 Steroid SpA Major Business
9.5.3 Steroid SpA Progesterone API Product and Services
9.5.4 Steroid SpA Progesterone API Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Steroid SpA Recent Developments/Updates
9.5.6 Steroid SpA Competitive Strengths & Weaknesses
9.6 Symbiotec Pharmalab
9.6.1 Symbiotec Pharmalab Details
9.6.2 Symbiotec Pharmalab Major Business
9.6.3 Symbiotec Pharmalab Progesterone API Product and Services
9.6.4 Symbiotec Pharmalab Progesterone API Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Symbiotec Pharmalab Recent Developments/Updates
9.6.6 Symbiotec Pharmalab Competitive Strengths & Weaknesses
9.7 Sun Pharmaceutical Industries
9.7.1 Sun Pharmaceutical Industries Details
9.7.2 Sun Pharmaceutical Industries Major Business
9.7.3 Sun Pharmaceutical Industries Progesterone API Product and Services
9.7.4 Sun Pharmaceutical Industries Progesterone API Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Sun Pharmaceutical Industries Recent Developments/Updates
9.7.6 Sun Pharmaceutical Industries Competitive Strengths & Weaknesses
9.8 Cipla
9.8.1 Cipla Details
9.8.2 Cipla Major Business
9.8.3 Cipla Progesterone API Product and Services
9.8.4 Cipla Progesterone API Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Cipla Recent Developments/Updates
9.8.6 Cipla Competitive Strengths & Weaknesses
9.9 Zydus Lifesciences
9.9.1 Zydus Lifesciences Details
9.9.2 Zydus Lifesciences Major Business
9.9.3 Zydus Lifesciences Progesterone API Product and Services
9.9.4 Zydus Lifesciences Progesterone API Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Zydus Lifesciences Recent Developments/Updates
9.9.6 Zydus Lifesciences Competitive Strengths & Weaknesses
9.10 Aurobindo Pharma
9.10.1 Aurobindo Pharma Details
9.10.2 Aurobindo Pharma Major Business
9.10.3 Aurobindo Pharma Progesterone API Product and Services
9.10.4 Aurobindo Pharma Progesterone API Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 Aurobindo Pharma Recent Developments/Updates
9.10.6 Aurobindo Pharma Competitive Strengths & Weaknesses
9.11 Tianjin Tianyao Pharmaceuticals
9.11.1 Tianjin Tianyao Pharmaceuticals Details
9.11.2 Tianjin Tianyao Pharmaceuticals Major Business
9.11.3 Tianjin Tianyao Pharmaceuticals Progesterone API Product and Services
9.11.4 Tianjin Tianyao Pharmaceuticals Progesterone API Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 Tianjin Tianyao Pharmaceuticals Recent Developments/Updates
9.11.6 Tianjin Tianyao Pharmaceuticals Competitive Strengths & Weaknesses
9.12 Zhejiang Xianju Pharmaceutical
9.12.1 Zhejiang Xianju Pharmaceutical Details
9.12.2 Zhejiang Xianju Pharmaceutical Major Business
9.12.3 Zhejiang Xianju Pharmaceutical Progesterone API Product and Services
9.12.4 Zhejiang Xianju Pharmaceutical Progesterone API Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 Zhejiang Xianju Pharmaceutical Recent Developments/Updates
9.12.6 Zhejiang Xianju Pharmaceutical Competitive Strengths & Weaknesses
9.13 Saituo Biological Technology
9.13.1 Saituo Biological Technology Details
9.13.2 Saituo Biological Technology Major Business
9.13.3 Saituo Biological Technology Progesterone API Product and Services
9.13.4 Saituo Biological Technology Progesterone API Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.13.5 Saituo Biological Technology Recent Developments/Updates
9.13.6 Saituo Biological Technology Competitive Strengths & Weaknesses
9.14 Zhejiang Xianju Xianle Pharmaceutical
9.14.1 Zhejiang Xianju Xianle Pharmaceutical Details
9.14.2 Zhejiang Xianju Xianle Pharmaceutical Major Business
9.14.3 Zhejiang Xianju Xianle Pharmaceutical Progesterone API Product and Services
9.14.4 Zhejiang Xianju Xianle Pharmaceutical Progesterone API Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.14.5 Zhejiang Xianju Xianle Pharmaceutical Recent Developments/Updates
9.14.6 Zhejiang Xianju Xianle Pharmaceutical Competitive Strengths & Weaknesses
9.15 Jiangsu Lianhuan Pharmaceutical
9.15.1 Jiangsu Lianhuan Pharmaceutical Details
9.15.2 Jiangsu Lianhuan Pharmaceutical Major Business
9.15.3 Jiangsu Lianhuan Pharmaceutical Progesterone API Product and Services
9.15.4 Jiangsu Lianhuan Pharmaceutical Progesterone API Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.15.5 Jiangsu Lianhuan Pharmaceutical Recent Developments/Updates
9.15.6 Jiangsu Lianhuan Pharmaceutical Competitive Strengths & Weaknesses
9.16 Zhejiang Xianju Junye Pharmaceutical
9.16.1 Zhejiang Xianju Junye Pharmaceutical Details
9.16.2 Zhejiang Xianju Junye Pharmaceutical Major Business
9.16.3 Zhejiang Xianju Junye Pharmaceutical Progesterone API Product and Services
9.16.4 Zhejiang Xianju Junye Pharmaceutical Progesterone API Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.16.5 Zhejiang Xianju Junye Pharmaceutical Recent Developments/Updates
9.16.6 Zhejiang Xianju Junye Pharmaceutical Competitive Strengths & Weaknesses
9.17 Zhejiang Shenzhou Pharmaceutical
9.17.1 Zhejiang Shenzhou Pharmaceutical Details
9.17.2 Zhejiang Shenzhou Pharmaceutical Major Business
9.17.3 Zhejiang Shenzhou Pharmaceutical Progesterone API Product and Services
9.17.4 Zhejiang Shenzhou Pharmaceutical Progesterone API Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.17.5 Zhejiang Shenzhou Pharmaceutical Recent Developments/Updates
9.17.6 Zhejiang Shenzhou Pharmaceutical Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Progesterone API Industry Chain
10.2 Progesterone API Upstream Analysis
10.2.1 Progesterone API Core Raw Materials
10.2.2 Main Manufacturers of Progesterone API Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Progesterone API Production Mode
10.6 Progesterone API Procurement Model
10.7 Progesterone API Industry Sales Model and Sales Channels
10.7.1 Progesterone API Sales Model
10.7.2 Progesterone API Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Progesterone API Introduction
1.2 World Progesterone API Supply & Forecast
1.2.1 World Progesterone API Production Value (2021 & 2025 & 2032)
1.2.2 World Progesterone API Production (2021-2032)
1.2.3 World Progesterone API Pricing Trends (2021-2032)
1.3 World Progesterone API Production by Region (Based on Production Site)
1.3.1 World Progesterone API Production Value by Region (2021-2032)
1.3.2 World Progesterone API Production by Region (2021-2032)
1.3.3 World Progesterone API Average Price by Region (2021-2032)
1.3.4 North America Progesterone API Production (2021-2032)
1.3.5 Europe Progesterone API Production (2021-2032)
1.3.6 China Progesterone API Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Progesterone API Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Progesterone API Major Market Trends
2 DEMAND SUMMARY
2.1 World Progesterone API Demand (2021-2032)
2.2 World Progesterone API Consumption by Region
2.2.1 World Progesterone API Consumption by Region (2021-2026)
2.2.2 World Progesterone API Consumption Forecast by Region (2027-2032)
2.3 United States Progesterone API Consumption (2021-2032)
2.4 China Progesterone API Consumption (2021-2032)
2.5 Europe Progesterone API Consumption (2021-2032)
2.6 Japan Progesterone API Consumption (2021-2032)
2.7 South Korea Progesterone API Consumption (2021-2032)
2.8 ASEAN Progesterone API Consumption (2021-2032)
2.9 India Progesterone API Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Progesterone API Production Value by Manufacturer (2021-2026)
3.2 World Progesterone API Production by Manufacturer (2021-2026)
3.3 World Progesterone API Average Price by Manufacturer (2021-2026)
3.4 Progesterone API Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Progesterone API Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Progesterone API in 2025
3.5.3 Global Concentration Ratios (CR8) for Progesterone API in 2025
3.6 Progesterone API Market: Overall Company Footprint Analysis
3.6.1 Progesterone API Market: Region Footprint
3.6.2 Progesterone API Market: Company Product Type Footprint
3.6.3 Progesterone API Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Progesterone API Production Value Comparison
4.1.1 United States VS China: Progesterone API Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Progesterone API Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Progesterone API Production Comparison
4.2.1 United States VS China: Progesterone API Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Progesterone API Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Progesterone API Consumption Comparison
4.3.1 United States VS China: Progesterone API Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Progesterone API Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Progesterone API Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Progesterone API Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Progesterone API Production Value (2021-2026)
4.4.3 United States Based Manufacturers Progesterone API Production (2021-2026)
4.5 China Based Progesterone API Manufacturers and Market Share
4.5.1 China Based Progesterone API Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Progesterone API Production Value (2021-2026)
4.5.3 China Based Manufacturers Progesterone API Production (2021-2026)
4.6 Rest of World Based Progesterone API Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Progesterone API Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Progesterone API Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Progesterone API Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Progesterone API Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 High-compliance
5.2.2 Standard Generic-grade
5.3 Market Segment by Type
5.3.1 World Progesterone API Production by Type (2021-2032)
5.3.2 World Progesterone API Production Value by Type (2021-2032)
5.3.3 World Progesterone API Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY FORMULATION
6.1 World Progesterone API Market Size Overview by Formulation: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Formulation
6.2.1 Oral Formulation
6.2.2 Injectable
6.2.3 Vaginal Delivery Formulations
6.3 Market Segment by Formulation
6.3.1 World Progesterone API Production by Formulation (2021-2032)
6.3.2 World Progesterone API Production Value by Formulation (2021-2032)
6.3.3 World Progesterone API Average Price by Formulation (2021-2032)
7 MARKET ANALYSIS BY CLINICAL INDICATION
7.1 World Progesterone API Market Size Overview by Clinical Indication: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Clinical Indication
7.2.1 Luteal Phase Support in Assisted Reproductive Technology
7.2.2 Treatment of Luteal Phase Deficiency
7.2.3 Others
7.3 Market Segment by Clinical Indication
7.3.1 World Progesterone API Production by Clinical Indication (2021-2032)
7.3.2 World Progesterone API Production Value by Clinical Indication (2021-2032)
7.3.3 World Progesterone API Average Price by Clinical Indication (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Progesterone API Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Finished Dosage Form Manufacturers
8.2.2 CDMO/CMO
8.2.3 Others
8.3 Market Segment by Application
8.3.1 World Progesterone API Production by Application (2021-2032)
8.3.2 World Progesterone API Production Value by Application (2021-2032)
8.3.3 World Progesterone API Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Pfizer CentreOne
9.1.1 Pfizer CentreOne Details
9.1.2 Pfizer CentreOne Major Business
9.1.3 Pfizer CentreOne Progesterone API Product and Services
9.1.4 Pfizer CentreOne Progesterone API Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Pfizer CentreOne Recent Developments/Updates
9.1.6 Pfizer CentreOne Competitive Strengths & Weaknesses
9.2 EUROAPI
9.2.1 EUROAPI Details
9.2.2 EUROAPI Major Business
9.2.3 EUROAPI Progesterone API Product and Services
9.2.4 EUROAPI Progesterone API Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 EUROAPI Recent Developments/Updates
9.2.6 EUROAPI Competitive Strengths & Weaknesses
9.3 TAPI
9.3.1 TAPI Details
9.3.2 TAPI Major Business
9.3.3 TAPI Progesterone API Product and Services
9.3.4 TAPI Progesterone API Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 TAPI Recent Developments/Updates
9.3.6 TAPI Competitive Strengths & Weaknesses
9.4 Axplora
9.4.1 Axplora Details
9.4.2 Axplora Major Business
9.4.3 Axplora Progesterone API Product and Services
9.4.4 Axplora Progesterone API Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Axplora Recent Developments/Updates
9.4.6 Axplora Competitive Strengths & Weaknesses
9.5 Steroid SpA
9.5.1 Steroid SpA Details
9.5.2 Steroid SpA Major Business
9.5.3 Steroid SpA Progesterone API Product and Services
9.5.4 Steroid SpA Progesterone API Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Steroid SpA Recent Developments/Updates
9.5.6 Steroid SpA Competitive Strengths & Weaknesses
9.6 Symbiotec Pharmalab
9.6.1 Symbiotec Pharmalab Details
9.6.2 Symbiotec Pharmalab Major Business
9.6.3 Symbiotec Pharmalab Progesterone API Product and Services
9.6.4 Symbiotec Pharmalab Progesterone API Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Symbiotec Pharmalab Recent Developments/Updates
9.6.6 Symbiotec Pharmalab Competitive Strengths & Weaknesses
9.7 Sun Pharmaceutical Industries
9.7.1 Sun Pharmaceutical Industries Details
9.7.2 Sun Pharmaceutical Industries Major Business
9.7.3 Sun Pharmaceutical Industries Progesterone API Product and Services
9.7.4 Sun Pharmaceutical Industries Progesterone API Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Sun Pharmaceutical Industries Recent Developments/Updates
9.7.6 Sun Pharmaceutical Industries Competitive Strengths & Weaknesses
9.8 Cipla
9.8.1 Cipla Details
9.8.2 Cipla Major Business
9.8.3 Cipla Progesterone API Product and Services
9.8.4 Cipla Progesterone API Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Cipla Recent Developments/Updates
9.8.6 Cipla Competitive Strengths & Weaknesses
9.9 Zydus Lifesciences
9.9.1 Zydus Lifesciences Details
9.9.2 Zydus Lifesciences Major Business
9.9.3 Zydus Lifesciences Progesterone API Product and Services
9.9.4 Zydus Lifesciences Progesterone API Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Zydus Lifesciences Recent Developments/Updates
9.9.6 Zydus Lifesciences Competitive Strengths & Weaknesses
9.10 Aurobindo Pharma
9.10.1 Aurobindo Pharma Details
9.10.2 Aurobindo Pharma Major Business
9.10.3 Aurobindo Pharma Progesterone API Product and Services
9.10.4 Aurobindo Pharma Progesterone API Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 Aurobindo Pharma Recent Developments/Updates
9.10.6 Aurobindo Pharma Competitive Strengths & Weaknesses
9.11 Tianjin Tianyao Pharmaceuticals
9.11.1 Tianjin Tianyao Pharmaceuticals Details
9.11.2 Tianjin Tianyao Pharmaceuticals Major Business
9.11.3 Tianjin Tianyao Pharmaceuticals Progesterone API Product and Services
9.11.4 Tianjin Tianyao Pharmaceuticals Progesterone API Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 Tianjin Tianyao Pharmaceuticals Recent Developments/Updates
9.11.6 Tianjin Tianyao Pharmaceuticals Competitive Strengths & Weaknesses
9.12 Zhejiang Xianju Pharmaceutical
9.12.1 Zhejiang Xianju Pharmaceutical Details
9.12.2 Zhejiang Xianju Pharmaceutical Major Business
9.12.3 Zhejiang Xianju Pharmaceutical Progesterone API Product and Services
9.12.4 Zhejiang Xianju Pharmaceutical Progesterone API Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 Zhejiang Xianju Pharmaceutical Recent Developments/Updates
9.12.6 Zhejiang Xianju Pharmaceutical Competitive Strengths & Weaknesses
9.13 Saituo Biological Technology
9.13.1 Saituo Biological Technology Details
9.13.2 Saituo Biological Technology Major Business
9.13.3 Saituo Biological Technology Progesterone API Product and Services
9.13.4 Saituo Biological Technology Progesterone API Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.13.5 Saituo Biological Technology Recent Developments/Updates
9.13.6 Saituo Biological Technology Competitive Strengths & Weaknesses
9.14 Zhejiang Xianju Xianle Pharmaceutical
9.14.1 Zhejiang Xianju Xianle Pharmaceutical Details
9.14.2 Zhejiang Xianju Xianle Pharmaceutical Major Business
9.14.3 Zhejiang Xianju Xianle Pharmaceutical Progesterone API Product and Services
9.14.4 Zhejiang Xianju Xianle Pharmaceutical Progesterone API Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.14.5 Zhejiang Xianju Xianle Pharmaceutical Recent Developments/Updates
9.14.6 Zhejiang Xianju Xianle Pharmaceutical Competitive Strengths & Weaknesses
9.15 Jiangsu Lianhuan Pharmaceutical
9.15.1 Jiangsu Lianhuan Pharmaceutical Details
9.15.2 Jiangsu Lianhuan Pharmaceutical Major Business
9.15.3 Jiangsu Lianhuan Pharmaceutical Progesterone API Product and Services
9.15.4 Jiangsu Lianhuan Pharmaceutical Progesterone API Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.15.5 Jiangsu Lianhuan Pharmaceutical Recent Developments/Updates
9.15.6 Jiangsu Lianhuan Pharmaceutical Competitive Strengths & Weaknesses
9.16 Zhejiang Xianju Junye Pharmaceutical
9.16.1 Zhejiang Xianju Junye Pharmaceutical Details
9.16.2 Zhejiang Xianju Junye Pharmaceutical Major Business
9.16.3 Zhejiang Xianju Junye Pharmaceutical Progesterone API Product and Services
9.16.4 Zhejiang Xianju Junye Pharmaceutical Progesterone API Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.16.5 Zhejiang Xianju Junye Pharmaceutical Recent Developments/Updates
9.16.6 Zhejiang Xianju Junye Pharmaceutical Competitive Strengths & Weaknesses
9.17 Zhejiang Shenzhou Pharmaceutical
9.17.1 Zhejiang Shenzhou Pharmaceutical Details
9.17.2 Zhejiang Shenzhou Pharmaceutical Major Business
9.17.3 Zhejiang Shenzhou Pharmaceutical Progesterone API Product and Services
9.17.4 Zhejiang Shenzhou Pharmaceutical Progesterone API Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.17.5 Zhejiang Shenzhou Pharmaceutical Recent Developments/Updates
9.17.6 Zhejiang Shenzhou Pharmaceutical Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Progesterone API Industry Chain
10.2 Progesterone API Upstream Analysis
10.2.1 Progesterone API Core Raw Materials
10.2.2 Main Manufacturers of Progesterone API Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Progesterone API Production Mode
10.6 Progesterone API Procurement Model
10.7 Progesterone API Industry Sales Model and Sales Channels
10.7.1 Progesterone API Sales Model
10.7.2 Progesterone API Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Progesterone API Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Progesterone API Production Value by Region (2021-2026) & (USD Million)
Table 3. World Progesterone API Production Value by Region (2027-2032) & (USD Million)
Table 4. World Progesterone API Production Value Market Share by Region (2021-2026)
Table 5. World Progesterone API Production Value Market Share by Region (2027-2032)
Table 6. World Progesterone API Production by Region (2021-2026) & (Tons)
Table 7. World Progesterone API Production by Region (2027-2032) & (Tons)
Table 8. World Progesterone API Production Market Share by Region (2021-2026)
Table 9. World Progesterone API Production Market Share by Region (2027-2032)
Table 10. World Progesterone API Average Price by Region (2021-2026) & (US$/kg)
Table 11. World Progesterone API Average Price by Region (2027-2032) & (US$/kg)
Table 12. Progesterone API Major Market Trends
Table 13. World Progesterone API Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Tons)
Table 14. World Progesterone API Consumption by Region (2021-2026) & (Tons)
Table 15. World Progesterone API Consumption Forecast by Region (2027-2032) & (Tons)
Table 16. World Progesterone API Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Progesterone API Producers in 2025
Table 18. World Progesterone API Production by Manufacturer (2021-2026) & (Tons)
Table 19. Production Market Share of Key Progesterone API Producers in 2025
Table 20. World Progesterone API Average Price by Manufacturer (2021-2026) & (US$/kg)
Table 21. Global Progesterone API Company Evaluation Quadrant
Table 22. World Progesterone API Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Progesterone API Production Site of Key Manufacturer
Table 24. Progesterone API Market: Company Product Type Footprint
Table 25. Progesterone API Market: Company Product Application Footprint
Table 26. Progesterone API Competitive Factors
Table 27. Progesterone API New Entrant and Capacity Expansion Plans
Table 28. Progesterone API Mergers & Acquisitions Activity
Table 29. United States VS China Progesterone API Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Progesterone API Production Comparison, (2021 & 2025 & 2032) & (Tons)
Table 31. United States VS China Progesterone API Consumption Comparison, (2021 & 2025 & 2032) & (Tons)
Table 32. United States Based Progesterone API Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Progesterone API Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Progesterone API Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Progesterone API Production (2021-2026) & (Tons)
Table 36. United States Based Manufacturers Progesterone API Production Market Share (2021-2026)
Table 37. China Based Progesterone API Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Progesterone API Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Progesterone API Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Progesterone API Production, (2021-2026) & (Tons)
Table 41. China Based Manufacturers Progesterone API Production Market Share (2021-2026)
Table 42. Rest of World Based Progesterone API Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Progesterone API Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Progesterone API Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Progesterone API Production, (2021-2026) & (Tons)
Table 46. Rest of World Based Manufacturers Progesterone API Production Market Share (2021-2026)
Table 47. World Progesterone API Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Progesterone API Production by Type (2021-2026) & (Tons)
Table 49. World Progesterone API Production by Type (2027-2032) & (Tons)
Table 50. World Progesterone API Production Value by Type (2021-2026) & (USD Million)
Table 51. World Progesterone API Production Value by Type (2027-2032) & (USD Million)
Table 52. World Progesterone API Average Price by Type (2021-2026) & (US$/kg)
Table 53. World Progesterone API Average Price by Type (2027-2032) & (US$/kg)
Table 54. World Progesterone API Production Value by Formulation, (USD Million), 2021 & 2025 & 2032
Table 55. World Progesterone API Production by Formulation (2021-2026) & (Tons)
Table 56. World Progesterone API Production by Formulation (2027-2032) & (Tons)
Table 57. World Progesterone API Production Value by Formulation (2021-2026) & (USD Million)
Table 58. World Progesterone API Production Value by Formulation (2027-2032) & (USD Million)
Table 59. World Progesterone API Average Price by Formulation (2021-2026) & (US$/kg)
Table 60. World Progesterone API Average Price by Formulation (2027-2032) & (US$/kg)
Table 61. World Progesterone API Production Value by Clinical Indication, (USD Million), 2021 & 2025 & 2032
Table 62. World Progesterone API Production by Clinical Indication (2021-2026) & (Tons)
Table 63. World Progesterone API Production by Clinical Indication (2027-2032) & (Tons)
Table 64. World Progesterone API Production Value by Clinical Indication (2021-2026) & (USD Million)
Table 65. World Progesterone API Production Value by Clinical Indication (2027-2032) & (USD Million)
Table 66. World Progesterone API Average Price by Clinical Indication (2021-2026) & (US$/kg)
Table 67. World Progesterone API Average Price by Clinical Indication (2027-2032) & (US$/kg)
Table 68. World Progesterone API Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Progesterone API Production by Application (2021-2026) & (Tons)
Table 70. World Progesterone API Production by Application (2027-2032) & (Tons)
Table 71. World Progesterone API Production Value by Application (2021-2026) & (USD Million)
Table 72. World Progesterone API Production Value by Application (2027-2032) & (USD Million)
Table 73. World Progesterone API Average Price by Application (2021-2026) & (US$/kg)
Table 74. World Progesterone API Average Price by Application (2027-2032) & (US$/kg)
Table 75. Pfizer CentreOne Basic Information, Manufacturing Base and Competitors
Table 76. Pfizer CentreOne Major Business
Table 77. Pfizer CentreOne Progesterone API Product and Services
Table 78. Pfizer CentreOne Progesterone API Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Pfizer CentreOne Recent Developments/Updates
Table 80. Pfizer CentreOne Competitive Strengths & Weaknesses
Table 81. EUROAPI Basic Information, Manufacturing Base and Competitors
Table 82. EUROAPI Major Business
Table 83. EUROAPI Progesterone API Product and Services
Table 84. EUROAPI Progesterone API Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. EUROAPI Recent Developments/Updates
Table 86. EUROAPI Competitive Strengths & Weaknesses
Table 87. TAPI Basic Information, Manufacturing Base and Competitors
Table 88. TAPI Major Business
Table 89. TAPI Progesterone API Product and Services
Table 90. TAPI Progesterone API Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. TAPI Recent Developments/Updates
Table 92. TAPI Competitive Strengths & Weaknesses
Table 93. Axplora Basic Information, Manufacturing Base and Competitors
Table 94. Axplora Major Business
Table 95. Axplora Progesterone API Product and Services
Table 96. Axplora Progesterone API Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Axplora Recent Developments/Updates
Table 98. Axplora Competitive Strengths & Weaknesses
Table 99. Steroid SpA Basic Information, Manufacturing Base and Competitors
Table 100. Steroid SpA Major Business
Table 101. Steroid SpA Progesterone API Product and Services
Table 102. Steroid SpA Progesterone API Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Steroid SpA Recent Developments/Updates
Table 104. Steroid SpA Competitive Strengths & Weaknesses
Table 105. Symbiotec Pharmalab Basic Information, Manufacturing Base and Competitors
Table 106. Symbiotec Pharmalab Major Business
Table 107. Symbiotec Pharmalab Progesterone API Product and Services
Table 108. Symbiotec Pharmalab Progesterone API Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Symbiotec Pharmalab Recent Developments/Updates
Table 110. Symbiotec Pharmalab Competitive Strengths & Weaknesses
Table 111. Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 112. Sun Pharmaceutical Industries Major Business
Table 113. Sun Pharmaceutical Industries Progesterone API Product and Services
Table 114. Sun Pharmaceutical Industries Progesterone API Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Sun Pharmaceutical Industries Recent Developments/Updates
Table 116. Sun Pharmaceutical Industries Competitive Strengths & Weaknesses
Table 117. Cipla Basic Information, Manufacturing Base and Competitors
Table 118. Cipla Major Business
Table 119. Cipla Progesterone API Product and Services
Table 120. Cipla Progesterone API Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Cipla Recent Developments/Updates
Table 122. Cipla Competitive Strengths & Weaknesses
Table 123. Zydus Lifesciences Basic Information, Manufacturing Base and Competitors
Table 124. Zydus Lifesciences Major Business
Table 125. Zydus Lifesciences Progesterone API Product and Services
Table 126. Zydus Lifesciences Progesterone API Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Zydus Lifesciences Recent Developments/Updates
Table 128. Zydus Lifesciences Competitive Strengths & Weaknesses
Table 129. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 130. Aurobindo Pharma Major Business
Table 131. Aurobindo Pharma Progesterone API Product and Services
Table 132. Aurobindo Pharma Progesterone API Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Aurobindo Pharma Recent Developments/Updates
Table 134. Aurobindo Pharma Competitive Strengths & Weaknesses
Table 135. Tianjin Tianyao Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 136. Tianjin Tianyao Pharmaceuticals Major Business
Table 137. Tianjin Tianyao Pharmaceuticals Progesterone API Product and Services
Table 138. Tianjin Tianyao Pharmaceuticals Progesterone API Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. Tianjin Tianyao Pharmaceuticals Recent Developments/Updates
Table 140. Tianjin Tianyao Pharmaceuticals Competitive Strengths & Weaknesses
Table 141. Zhejiang Xianju Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 142. Zhejiang Xianju Pharmaceutical Major Business
Table 143. Zhejiang Xianju Pharmaceutical Progesterone API Product and Services
Table 144. Zhejiang Xianju Pharmaceutical Progesterone API Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. Zhejiang Xianju Pharmaceutical Recent Developments/Updates
Table 146. Zhejiang Xianju Pharmaceutical Competitive Strengths & Weaknesses
Table 147. Saituo Biological Technology Basic Information, Manufacturing Base and Competitors
Table 148. Saituo Biological Technology Major Business
Table 149. Saituo Biological Technology Progesterone API Product and Services
Table 150. Saituo Biological Technology Progesterone API Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. Saituo Biological Technology Recent Developments/Updates
Table 152. Saituo Biological Technology Competitive Strengths & Weaknesses
Table 153. Zhejiang Xianju Xianle Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 154. Zhejiang Xianju Xianle Pharmaceutical Major Business
Table 155. Zhejiang Xianju Xianle Pharmaceutical Progesterone API Product and Services
Table 156. Zhejiang Xianju Xianle Pharmaceutical Progesterone API Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 157. Zhejiang Xianju Xianle Pharmaceutical Recent Developments/Updates
Table 158. Zhejiang Xianju Xianle Pharmaceutical Competitive Strengths & Weaknesses
Table 159. Jiangsu Lianhuan Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 160. Jiangsu Lianhuan Pharmaceutical Major Business
Table 161. Jiangsu Lianhuan Pharmaceutical Progesterone API Product and Services
Table 162. Jiangsu Lianhuan Pharmaceutical Progesterone API Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 163. Jiangsu Lianhuan Pharmaceutical Recent Developments/Updates
Table 164. Jiangsu Lianhuan Pharmaceutical Competitive Strengths & Weaknesses
Table 165. Zhejiang Xianju Junye Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 166. Zhejiang Xianju Junye Pharmaceutical Major Business
Table 167. Zhejiang Xianju Junye Pharmaceutical Progesterone API Product and Services
Table 168. Zhejiang Xianju Junye Pharmaceutical Progesterone API Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 169. Zhejiang Xianju Junye Pharmaceutical Recent Developments/Updates
Table 170. Zhejiang Xianju Junye Pharmaceutical Competitive Strengths & Weaknesses
Table 171. Zhejiang Shenzhou Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 172. Zhejiang Shenzhou Pharmaceutical Major Business
Table 173. Zhejiang Shenzhou Pharmaceutical Progesterone API Product and Services
Table 174. Zhejiang Shenzhou Pharmaceutical Progesterone API Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 175. Zhejiang Shenzhou Pharmaceutical Recent Developments/Updates
Table 176. Zhejiang Shenzhou Pharmaceutical Competitive Strengths & Weaknesses
Table 177. Global Key Players of Progesterone API Upstream (Raw Materials)
Table 178. Global Progesterone API Typical Customers
Table 179. Progesterone API Typical Distributors
Table 1. World Progesterone API Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Progesterone API Production Value by Region (2021-2026) & (USD Million)
Table 3. World Progesterone API Production Value by Region (2027-2032) & (USD Million)
Table 4. World Progesterone API Production Value Market Share by Region (2021-2026)
Table 5. World Progesterone API Production Value Market Share by Region (2027-2032)
Table 6. World Progesterone API Production by Region (2021-2026) & (Tons)
Table 7. World Progesterone API Production by Region (2027-2032) & (Tons)
Table 8. World Progesterone API Production Market Share by Region (2021-2026)
Table 9. World Progesterone API Production Market Share by Region (2027-2032)
Table 10. World Progesterone API Average Price by Region (2021-2026) & (US$/kg)
Table 11. World Progesterone API Average Price by Region (2027-2032) & (US$/kg)
Table 12. Progesterone API Major Market Trends
Table 13. World Progesterone API Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Tons)
Table 14. World Progesterone API Consumption by Region (2021-2026) & (Tons)
Table 15. World Progesterone API Consumption Forecast by Region (2027-2032) & (Tons)
Table 16. World Progesterone API Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Progesterone API Producers in 2025
Table 18. World Progesterone API Production by Manufacturer (2021-2026) & (Tons)
Table 19. Production Market Share of Key Progesterone API Producers in 2025
Table 20. World Progesterone API Average Price by Manufacturer (2021-2026) & (US$/kg)
Table 21. Global Progesterone API Company Evaluation Quadrant
Table 22. World Progesterone API Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Progesterone API Production Site of Key Manufacturer
Table 24. Progesterone API Market: Company Product Type Footprint
Table 25. Progesterone API Market: Company Product Application Footprint
Table 26. Progesterone API Competitive Factors
Table 27. Progesterone API New Entrant and Capacity Expansion Plans
Table 28. Progesterone API Mergers & Acquisitions Activity
Table 29. United States VS China Progesterone API Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Progesterone API Production Comparison, (2021 & 2025 & 2032) & (Tons)
Table 31. United States VS China Progesterone API Consumption Comparison, (2021 & 2025 & 2032) & (Tons)
Table 32. United States Based Progesterone API Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Progesterone API Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Progesterone API Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Progesterone API Production (2021-2026) & (Tons)
Table 36. United States Based Manufacturers Progesterone API Production Market Share (2021-2026)
Table 37. China Based Progesterone API Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Progesterone API Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Progesterone API Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Progesterone API Production, (2021-2026) & (Tons)
Table 41. China Based Manufacturers Progesterone API Production Market Share (2021-2026)
Table 42. Rest of World Based Progesterone API Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Progesterone API Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Progesterone API Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Progesterone API Production, (2021-2026) & (Tons)
Table 46. Rest of World Based Manufacturers Progesterone API Production Market Share (2021-2026)
Table 47. World Progesterone API Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Progesterone API Production by Type (2021-2026) & (Tons)
Table 49. World Progesterone API Production by Type (2027-2032) & (Tons)
Table 50. World Progesterone API Production Value by Type (2021-2026) & (USD Million)
Table 51. World Progesterone API Production Value by Type (2027-2032) & (USD Million)
Table 52. World Progesterone API Average Price by Type (2021-2026) & (US$/kg)
Table 53. World Progesterone API Average Price by Type (2027-2032) & (US$/kg)
Table 54. World Progesterone API Production Value by Formulation, (USD Million), 2021 & 2025 & 2032
Table 55. World Progesterone API Production by Formulation (2021-2026) & (Tons)
Table 56. World Progesterone API Production by Formulation (2027-2032) & (Tons)
Table 57. World Progesterone API Production Value by Formulation (2021-2026) & (USD Million)
Table 58. World Progesterone API Production Value by Formulation (2027-2032) & (USD Million)
Table 59. World Progesterone API Average Price by Formulation (2021-2026) & (US$/kg)
Table 60. World Progesterone API Average Price by Formulation (2027-2032) & (US$/kg)
Table 61. World Progesterone API Production Value by Clinical Indication, (USD Million), 2021 & 2025 & 2032
Table 62. World Progesterone API Production by Clinical Indication (2021-2026) & (Tons)
Table 63. World Progesterone API Production by Clinical Indication (2027-2032) & (Tons)
Table 64. World Progesterone API Production Value by Clinical Indication (2021-2026) & (USD Million)
Table 65. World Progesterone API Production Value by Clinical Indication (2027-2032) & (USD Million)
Table 66. World Progesterone API Average Price by Clinical Indication (2021-2026) & (US$/kg)
Table 67. World Progesterone API Average Price by Clinical Indication (2027-2032) & (US$/kg)
Table 68. World Progesterone API Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Progesterone API Production by Application (2021-2026) & (Tons)
Table 70. World Progesterone API Production by Application (2027-2032) & (Tons)
Table 71. World Progesterone API Production Value by Application (2021-2026) & (USD Million)
Table 72. World Progesterone API Production Value by Application (2027-2032) & (USD Million)
Table 73. World Progesterone API Average Price by Application (2021-2026) & (US$/kg)
Table 74. World Progesterone API Average Price by Application (2027-2032) & (US$/kg)
Table 75. Pfizer CentreOne Basic Information, Manufacturing Base and Competitors
Table 76. Pfizer CentreOne Major Business
Table 77. Pfizer CentreOne Progesterone API Product and Services
Table 78. Pfizer CentreOne Progesterone API Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Pfizer CentreOne Recent Developments/Updates
Table 80. Pfizer CentreOne Competitive Strengths & Weaknesses
Table 81. EUROAPI Basic Information, Manufacturing Base and Competitors
Table 82. EUROAPI Major Business
Table 83. EUROAPI Progesterone API Product and Services
Table 84. EUROAPI Progesterone API Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. EUROAPI Recent Developments/Updates
Table 86. EUROAPI Competitive Strengths & Weaknesses
Table 87. TAPI Basic Information, Manufacturing Base and Competitors
Table 88. TAPI Major Business
Table 89. TAPI Progesterone API Product and Services
Table 90. TAPI Progesterone API Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. TAPI Recent Developments/Updates
Table 92. TAPI Competitive Strengths & Weaknesses
Table 93. Axplora Basic Information, Manufacturing Base and Competitors
Table 94. Axplora Major Business
Table 95. Axplora Progesterone API Product and Services
Table 96. Axplora Progesterone API Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Axplora Recent Developments/Updates
Table 98. Axplora Competitive Strengths & Weaknesses
Table 99. Steroid SpA Basic Information, Manufacturing Base and Competitors
Table 100. Steroid SpA Major Business
Table 101. Steroid SpA Progesterone API Product and Services
Table 102. Steroid SpA Progesterone API Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Steroid SpA Recent Developments/Updates
Table 104. Steroid SpA Competitive Strengths & Weaknesses
Table 105. Symbiotec Pharmalab Basic Information, Manufacturing Base and Competitors
Table 106. Symbiotec Pharmalab Major Business
Table 107. Symbiotec Pharmalab Progesterone API Product and Services
Table 108. Symbiotec Pharmalab Progesterone API Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Symbiotec Pharmalab Recent Developments/Updates
Table 110. Symbiotec Pharmalab Competitive Strengths & Weaknesses
Table 111. Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 112. Sun Pharmaceutical Industries Major Business
Table 113. Sun Pharmaceutical Industries Progesterone API Product and Services
Table 114. Sun Pharmaceutical Industries Progesterone API Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Sun Pharmaceutical Industries Recent Developments/Updates
Table 116. Sun Pharmaceutical Industries Competitive Strengths & Weaknesses
Table 117. Cipla Basic Information, Manufacturing Base and Competitors
Table 118. Cipla Major Business
Table 119. Cipla Progesterone API Product and Services
Table 120. Cipla Progesterone API Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Cipla Recent Developments/Updates
Table 122. Cipla Competitive Strengths & Weaknesses
Table 123. Zydus Lifesciences Basic Information, Manufacturing Base and Competitors
Table 124. Zydus Lifesciences Major Business
Table 125. Zydus Lifesciences Progesterone API Product and Services
Table 126. Zydus Lifesciences Progesterone API Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Zydus Lifesciences Recent Developments/Updates
Table 128. Zydus Lifesciences Competitive Strengths & Weaknesses
Table 129. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 130. Aurobindo Pharma Major Business
Table 131. Aurobindo Pharma Progesterone API Product and Services
Table 132. Aurobindo Pharma Progesterone API Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Aurobindo Pharma Recent Developments/Updates
Table 134. Aurobindo Pharma Competitive Strengths & Weaknesses
Table 135. Tianjin Tianyao Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 136. Tianjin Tianyao Pharmaceuticals Major Business
Table 137. Tianjin Tianyao Pharmaceuticals Progesterone API Product and Services
Table 138. Tianjin Tianyao Pharmaceuticals Progesterone API Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. Tianjin Tianyao Pharmaceuticals Recent Developments/Updates
Table 140. Tianjin Tianyao Pharmaceuticals Competitive Strengths & Weaknesses
Table 141. Zhejiang Xianju Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 142. Zhejiang Xianju Pharmaceutical Major Business
Table 143. Zhejiang Xianju Pharmaceutical Progesterone API Product and Services
Table 144. Zhejiang Xianju Pharmaceutical Progesterone API Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. Zhejiang Xianju Pharmaceutical Recent Developments/Updates
Table 146. Zhejiang Xianju Pharmaceutical Competitive Strengths & Weaknesses
Table 147. Saituo Biological Technology Basic Information, Manufacturing Base and Competitors
Table 148. Saituo Biological Technology Major Business
Table 149. Saituo Biological Technology Progesterone API Product and Services
Table 150. Saituo Biological Technology Progesterone API Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. Saituo Biological Technology Recent Developments/Updates
Table 152. Saituo Biological Technology Competitive Strengths & Weaknesses
Table 153. Zhejiang Xianju Xianle Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 154. Zhejiang Xianju Xianle Pharmaceutical Major Business
Table 155. Zhejiang Xianju Xianle Pharmaceutical Progesterone API Product and Services
Table 156. Zhejiang Xianju Xianle Pharmaceutical Progesterone API Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 157. Zhejiang Xianju Xianle Pharmaceutical Recent Developments/Updates
Table 158. Zhejiang Xianju Xianle Pharmaceutical Competitive Strengths & Weaknesses
Table 159. Jiangsu Lianhuan Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 160. Jiangsu Lianhuan Pharmaceutical Major Business
Table 161. Jiangsu Lianhuan Pharmaceutical Progesterone API Product and Services
Table 162. Jiangsu Lianhuan Pharmaceutical Progesterone API Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 163. Jiangsu Lianhuan Pharmaceutical Recent Developments/Updates
Table 164. Jiangsu Lianhuan Pharmaceutical Competitive Strengths & Weaknesses
Table 165. Zhejiang Xianju Junye Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 166. Zhejiang Xianju Junye Pharmaceutical Major Business
Table 167. Zhejiang Xianju Junye Pharmaceutical Progesterone API Product and Services
Table 168. Zhejiang Xianju Junye Pharmaceutical Progesterone API Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 169. Zhejiang Xianju Junye Pharmaceutical Recent Developments/Updates
Table 170. Zhejiang Xianju Junye Pharmaceutical Competitive Strengths & Weaknesses
Table 171. Zhejiang Shenzhou Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 172. Zhejiang Shenzhou Pharmaceutical Major Business
Table 173. Zhejiang Shenzhou Pharmaceutical Progesterone API Product and Services
Table 174. Zhejiang Shenzhou Pharmaceutical Progesterone API Production (Tons), Price (US$/kg), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 175. Zhejiang Shenzhou Pharmaceutical Recent Developments/Updates
Table 176. Zhejiang Shenzhou Pharmaceutical Competitive Strengths & Weaknesses
Table 177. Global Key Players of Progesterone API Upstream (Raw Materials)
Table 178. Global Progesterone API Typical Customers
Table 179. Progesterone API Typical Distributors
LIST OF FIGURES
Figure 1. Progesterone API Picture
Figure 2. World Progesterone API Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Progesterone API Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Progesterone API Production (2021-2032) & (Tons)
Figure 5. World Progesterone API Average Price (2021-2032) & (US$/kg)
Figure 6. World Progesterone API Production Value Market Share by Region (2021-2032)
Figure 7. World Progesterone API Production Market Share by Region (2021-2032)
Figure 8. North America Progesterone API Production (2021-2032) & (Tons)
Figure 9. Europe Progesterone API Production (2021-2032) & (Tons)
Figure 10. China Progesterone API Production (2021-2032) & (Tons)
Figure 11. Progesterone API Market Drivers
Figure 12. Factors Affecting Demand
Figure 13. World Progesterone API Consumption (2021-2032) & (Tons)
Figure 14. World Progesterone API Consumption Market Share by Region (2021-2032)
Figure 15. United States Progesterone API Consumption (2021-2032) & (Tons)
Figure 16. China Progesterone API Consumption (2021-2032) & (Tons)
Figure 17. Europe Progesterone API Consumption (2021-2032) & (Tons)
Figure 18. Japan Progesterone API Consumption (2021-2032) & (Tons)
Figure 19. South Korea Progesterone API Consumption (2021-2032) & (Tons)
Figure 20. ASEAN Progesterone API Consumption (2021-2032) & (Tons)
Figure 21. India Progesterone API Consumption (2021-2032) & (Tons)
Figure 22. Producer Shipments of Progesterone API by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 23. Global Four-firm Concentration Ratios (CR4) for Progesterone API Markets in 2025
Figure 24. Global Four-firm Concentration Ratios (CR8) for Progesterone API Markets in 2025
Figure 25. United States VS China: Progesterone API Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 26. United States VS China: Progesterone API Production Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Progesterone API Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States Based Manufacturers Progesterone API Production Market Share 2025
Figure 29. China Based Manufacturers Progesterone API Production Market Share 2025
Figure 30. Rest of World Based Manufacturers Progesterone API Production Market Share 2025
Figure 31. World Progesterone API Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 32. World Progesterone API Production Value Market Share by Type in 2025
Figure 33. High-compliance
Figure 34. Standard Generic-grade
Figure 35. World Progesterone API Production Market Share by Type (2021-2032)
Figure 36. World Progesterone API Production Value Market Share by Type (2021-2032)
Figure 37. World Progesterone API Average Price by Type (2021-2032) & (US$/kg)
Figure 38. World Progesterone API Production Value by Formulation, (USD Million), 2021 & 2025 & 2032
Figure 39. World Progesterone API Production Value Market Share by Formulation in 2025
Figure 40. Oral Formulation
Figure 41. Injectable
Figure 42. Vaginal Delivery Formulations
Figure 43. World Progesterone API Production Market Share by Formulation (2021-2032)
Figure 44. World Progesterone API Production Value Market Share by Formulation (2021-2032)
Figure 45. World Progesterone API Average Price by Formulation (2021-2032) & (US$/kg)
Figure 46. World Progesterone API Production Value by Clinical Indication, (USD Million), 2021 & 2025 & 2032
Figure 47. World Progesterone API Production Value Market Share by Clinical Indication in 2025
Figure 48. Luteal Phase Support in Assisted Reproductive Technology
Figure 49. Treatment of Luteal Phase Deficiency
Figure 50. Others
Figure 51. World Progesterone API Production Market Share by Clinical Indication (2021-2032)
Figure 52. World Progesterone API Production Value Market Share by Clinical Indication (2021-2032)
Figure 53. World Progesterone API Average Price by Clinical Indication (2021-2032) & (US$/kg)
Figure 54. World Progesterone API Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 55. World Progesterone API Production Value Market Share by Application in 2025
Figure 56. Finished Dosage Form Manufacturers
Figure 57. CDMO/CMO
Figure 58. Others
Figure 59. World Progesterone API Production Market Share by Application (2021-2032)
Figure 60. World Progesterone API Production Value Market Share by Application (2021-2032)
Figure 61. World Progesterone API Average Price by Application (2021-2032) & (US$/kg)
Figure 62. Progesterone API Industry Chain
Figure 63. Progesterone API Procurement Model
Figure 64. Progesterone API Sales Model
Figure 65. Progesterone API Sales Channels, Direct Sales, and Distribution
Figure 66. Methodology
Figure 67. Research Process and Data Source
Figure 1. Progesterone API Picture
Figure 2. World Progesterone API Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Progesterone API Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Progesterone API Production (2021-2032) & (Tons)
Figure 5. World Progesterone API Average Price (2021-2032) & (US$/kg)
Figure 6. World Progesterone API Production Value Market Share by Region (2021-2032)
Figure 7. World Progesterone API Production Market Share by Region (2021-2032)
Figure 8. North America Progesterone API Production (2021-2032) & (Tons)
Figure 9. Europe Progesterone API Production (2021-2032) & (Tons)
Figure 10. China Progesterone API Production (2021-2032) & (Tons)
Figure 11. Progesterone API Market Drivers
Figure 12. Factors Affecting Demand
Figure 13. World Progesterone API Consumption (2021-2032) & (Tons)
Figure 14. World Progesterone API Consumption Market Share by Region (2021-2032)
Figure 15. United States Progesterone API Consumption (2021-2032) & (Tons)
Figure 16. China Progesterone API Consumption (2021-2032) & (Tons)
Figure 17. Europe Progesterone API Consumption (2021-2032) & (Tons)
Figure 18. Japan Progesterone API Consumption (2021-2032) & (Tons)
Figure 19. South Korea Progesterone API Consumption (2021-2032) & (Tons)
Figure 20. ASEAN Progesterone API Consumption (2021-2032) & (Tons)
Figure 21. India Progesterone API Consumption (2021-2032) & (Tons)
Figure 22. Producer Shipments of Progesterone API by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 23. Global Four-firm Concentration Ratios (CR4) for Progesterone API Markets in 2025
Figure 24. Global Four-firm Concentration Ratios (CR8) for Progesterone API Markets in 2025
Figure 25. United States VS China: Progesterone API Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 26. United States VS China: Progesterone API Production Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Progesterone API Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States Based Manufacturers Progesterone API Production Market Share 2025
Figure 29. China Based Manufacturers Progesterone API Production Market Share 2025
Figure 30. Rest of World Based Manufacturers Progesterone API Production Market Share 2025
Figure 31. World Progesterone API Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 32. World Progesterone API Production Value Market Share by Type in 2025
Figure 33. High-compliance
Figure 34. Standard Generic-grade
Figure 35. World Progesterone API Production Market Share by Type (2021-2032)
Figure 36. World Progesterone API Production Value Market Share by Type (2021-2032)
Figure 37. World Progesterone API Average Price by Type (2021-2032) & (US$/kg)
Figure 38. World Progesterone API Production Value by Formulation, (USD Million), 2021 & 2025 & 2032
Figure 39. World Progesterone API Production Value Market Share by Formulation in 2025
Figure 40. Oral Formulation
Figure 41. Injectable
Figure 42. Vaginal Delivery Formulations
Figure 43. World Progesterone API Production Market Share by Formulation (2021-2032)
Figure 44. World Progesterone API Production Value Market Share by Formulation (2021-2032)
Figure 45. World Progesterone API Average Price by Formulation (2021-2032) & (US$/kg)
Figure 46. World Progesterone API Production Value by Clinical Indication, (USD Million), 2021 & 2025 & 2032
Figure 47. World Progesterone API Production Value Market Share by Clinical Indication in 2025
Figure 48. Luteal Phase Support in Assisted Reproductive Technology
Figure 49. Treatment of Luteal Phase Deficiency
Figure 50. Others
Figure 51. World Progesterone API Production Market Share by Clinical Indication (2021-2032)
Figure 52. World Progesterone API Production Value Market Share by Clinical Indication (2021-2032)
Figure 53. World Progesterone API Average Price by Clinical Indication (2021-2032) & (US$/kg)
Figure 54. World Progesterone API Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 55. World Progesterone API Production Value Market Share by Application in 2025
Figure 56. Finished Dosage Form Manufacturers
Figure 57. CDMO/CMO
Figure 58. Others
Figure 59. World Progesterone API Production Market Share by Application (2021-2032)
Figure 60. World Progesterone API Production Value Market Share by Application (2021-2032)
Figure 61. World Progesterone API Average Price by Application (2021-2032) & (US$/kg)
Figure 62. Progesterone API Industry Chain
Figure 63. Progesterone API Procurement Model
Figure 64. Progesterone API Sales Model
Figure 65. Progesterone API Sales Channels, Direct Sales, and Distribution
Figure 66. Methodology
Figure 67. Research Process and Data Source
